Biosimilar Development solution center
-
ADCs: The Next Phase Of Innovation
4/24/2025
Explore the pivotal advancements in ADCs that focus on high-DAR, multispecific designs, and novel payloads, while addressing challenges in manufacturability, scalability, regulatory acceptance, and commercial viability.
-
Indian Biosimilar Companies Are Poised To Succeed In The Global Market
3/31/2025
For Indian biosimilar developers looking to capitalize on the upcoming patent cliff, it is vital to play to your strengths and identify strategies for breaking into competitive regulatory markets.
-
Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines
3/24/2025
Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.
-
A 5-Step Guide To Achieving Your Biosimilar Milestones On Time
3/24/2025
As the biologic patent cliff looms, biosimilar developers must strategically plot their approach to development and manufacturing to secure a corner of their market and reach their target patients.
-
Thunderstruck By Antibody-Drug Conjugates
3/18/2025
Antibody-drug conjugates are transforming cancer treatment by targeting tumors directly to reduce side effects. Discover how they affect neighboring cells, which can enhance treatment efficacy and eliminate tumor cell populations.
-
The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly
3/3/2025
In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.
-
U.S. Biosimilars Surge: Clinical Trials, Regulatory Shifts, And The Path To Dominance
2/28/2025
Joseph Pategou asks and answers, "Where does the U.S. biosimilar market stand now?"
-
Multi-Attribute Method Analysis In Biopharmaceutical Development
2/26/2025
Analytics is a crucial element in biopharmaceutical development and manufacturing. Discover how Multi-Attribute Method (MAM) revolutionizes analytics to enhance quality control and regulatory compliance.
-
Emerging Trends In mAbs Manufacturing In 2025 And Beyond
2/11/2025
Two key innovations — continuous perfusion in upstream processing and multicolumn chromatography in downstream processing — are having a profound impact on biologics manufacturing.
-
Clinical Regulatory Changes One Of Many Tailwinds For Biosimilars
2/10/2025
With an projected global market value of $35.7 billion in 2025, biosimilars are slated for considerable growth opportunities, thanks in part to clinical regulatory changes.